SRX Global Announces Share Consolidation
SRX Global (NYSE American: SRXH) will implement a 60-to-1 share consolidation of its issued and outstanding common stock, effective July 6, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
SRX Global (NYSE American: SRXH) will implement a 60-to-1 share consolidation of its issued and outstanding common stock, effective July 6, 2026. Every 60 existing shares will automatically convert into one share on the Effective Date.
The stock will continue trading on NYSE American under the symbol SRXH and will trade on a consolidated basis with a new CUSIP from market open on July 6, 2026. No fractional shares will be issued; eligible holders will receive one whole share instead.
Positive
- 60-to-1 share consolidation effective July 6, 2026
- No fractional shares; smallest position rounded up to one whole share
- Shares begin trading under new CUSIP on Effective Date
Negative
- Each 60 existing common shares converted into one post-consolidation share
Key Figures
- Share consolidation ratio
- 60-to-1
- Board-approved consolidation of common stock
- Effective date
- July 6, 2026
- Share consolidation effective date
- Pre-consolidation shares per post share
- 60 shares
- Every 60 existing shares combine into one
- Post-consolidation share count per lot
- one share
- Resulting common stock after combining 60 shares
- Fractional share treatment
- one whole share
- In lieu of any fractional share from consolidation
Historical Context
-
Investment in ARMR Sciences’ clinical-stage biodefense program and lead candidate ARMR-100.
-
Closing EMJX acquisition and launching AI-driven capital allocation platform under SRX Global.
-
Acquisition of 4.99% of Smartkem plus convertible preferred securities via financing structures.
-
Updated positions in Uber, Compass, Bitcoin and hedges alongside merger progress disclosure.
-
Investment in Optimi Health, a commercial-stage psychedelic pharmaceutical company post-IPO.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
cusip number regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
NORTH PALM BEACH, Fla., June 24, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE American: SRXH) (the "Company", or “SRX”), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that its Board of Directors has approved a consolidation of the Company's issued and outstanding common stock on a 60-to-1 basis (the “Share Consolidation”), to be effective July 6, 2026 (the “Effective Date”).
On the Effective Date, every 60 shares of issued and outstanding common stock will be automatically combined into one share of common stock. The Company's common stock will continue to trade on the NYSE American under the existing symbol “SRXH” and will begin trading on a consolidated basis under a new CUSIP number at market open on the Effective Date. No fractional shares will be issued in connection with the Share Consolidation; any shareholder who would otherwise be entitled to a fractional share will receive one whole share in lieu thereof.
About SRX Global Inc.
SRX Global is an AI-driven platform focused on generating long-term shareholder value through investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. The Company leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across multiple sectors.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "expect," "intend," "aim," "plan," "may," "could," "target," and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the Share Consolidation, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company's filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.
Company Contact
SRX Global
Kent Cunningham, Chief Executive Officer
Investor Relations Contact
KCSA Strategic Communications
Valter Pinto, Managing Director
212-896-1254
srx@kcsa.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.